DK645488A - Topiske metronidazol-praeparater og terapeutiske anvendelser deraf - Google Patents

Topiske metronidazol-praeparater og terapeutiske anvendelser deraf

Info

Publication number
DK645488A
DK645488A DK645488A DK645488A DK645488A DK 645488 A DK645488 A DK 645488A DK 645488 A DK645488 A DK 645488A DK 645488 A DK645488 A DK 645488A DK 645488 A DK645488 A DK 645488A
Authority
DK
Denmark
Prior art keywords
preparations
formulations
therapeutic applications
drug
metronidazole
Prior art date
Application number
DK645488A
Other languages
English (en)
Other versions
DK645488D0 (da
DK173844B1 (da
Inventor
Robert John Borgman
Original Assignee
Curatek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK645488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Curatek Pharmaceuticals filed Critical Curatek Pharmaceuticals
Publication of DK645488D0 publication Critical patent/DK645488D0/da
Publication of DK645488A publication Critical patent/DK645488A/da
Application granted granted Critical
Publication of DK173844B1 publication Critical patent/DK173844B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Cosmetics (AREA)
DK198806454A 1987-03-20 1988-11-18 Topiske metronidazol-præparater DK173844B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8700584 1987-03-20
PCT/US1987/000584 WO1988006888A1 (en) 1987-03-20 1987-03-20 Novel topical metronidazole formulations and therapeutic uses thereof

Publications (3)

Publication Number Publication Date
DK645488D0 DK645488D0 (da) 1988-11-18
DK645488A true DK645488A (da) 1989-01-19
DK173844B1 DK173844B1 (da) 2001-12-10

Family

ID=22202320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806454A DK173844B1 (da) 1987-03-20 1988-11-18 Topiske metronidazol-præparater

Country Status (10)

Country Link
EP (1) EP0305380B1 (da)
JP (1) JPH0825878B2 (da)
KR (1) KR950003919B1 (da)
AT (1) ATE67667T1 (da)
AU (1) AU610495B2 (da)
DE (1) DE3773383D1 (da)
DK (1) DK173844B1 (da)
FI (1) FI88582C (da)
NO (1) NO175883C (da)
WO (1) WO1988006888A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4859694A (en) * 1988-02-10 1989-08-22 Pavlich Frederick M Method for treating hoof thrush and hoof rot
GB8910076D0 (en) † 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
GB9415290D0 (en) * 1994-07-28 1994-09-21 Zeneca Ltd Gel formation
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
HUE033144T2 (en) 2010-03-12 2017-11-28 Monsanto Technology Llc Agrochemical gel preparations
CN103763925A (zh) 2011-06-28 2014-04-30 梅迪奇制药有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性阴道病的用途
CA2916002A1 (en) 2013-06-25 2014-12-31 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2022269665A1 (ja) * 2021-06-21 2022-12-29 マルホ株式会社 外用剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883661A (en) * 1971-11-09 1975-05-13 Syntex Inc Acne treatment
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment

Also Published As

Publication number Publication date
AU7233787A (en) 1988-10-10
EP0305380B1 (en) 1991-09-25
DK645488D0 (da) 1988-11-18
WO1988006888A1 (en) 1988-09-22
DK173844B1 (da) 2001-12-10
NO885172L (no) 1988-11-18
KR890701113A (ko) 1989-12-19
NO175883C (no) 1994-12-28
NO885172D0 (no) 1988-11-18
FI88582B (fi) 1993-02-26
FI885377A (fi) 1988-11-18
FI88582C (fi) 1993-06-10
JPH0825878B2 (ja) 1996-03-13
DE3773383D1 (de) 1991-10-31
NO175883B (no) 1994-09-19
JPH01503061A (ja) 1989-10-19
FI885377A0 (fi) 1988-11-18
EP0305380A1 (en) 1989-03-08
EP0305380A4 (en) 1989-06-26
KR950003919B1 (ko) 1995-04-20
AU610495B2 (en) 1991-05-23
ATE67667T1 (de) 1991-10-15

Similar Documents

Publication Publication Date Title
DK645488A (da) Topiske metronidazol-praeparater og terapeutiske anvendelser deraf
ZA89233B (en) Topical metronidazole formulations and therapeutic uses thereof
DK165440C (da) Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
HUP9801234A2 (hu) Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
BR9205713A (pt) Ingrediente ativo de secreçao de gastrópode, processo para sua preparaçao, e composiçao de ingrediente ativo
DE3689380T2 (de) Chemische Derivate von GHL-Cu.
KR890007736A (ko) 11,28-디옥사-4-아자트리시클로[22.3.1.0^4·9]옥타코스-18-엔 유도체 및 이들을 함유한 약학적 조성물의 사용방법
FI862609A0 (fi) Akne motverkande produkt.
KR930012013A (ko) 건선과 과민성 피부염 치료에 국소적으로 사용되는 제약학적 성분물
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
DK522186A (da) Melatoninmaterialer og deres anvendelser
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
FI913100A0 (fi) Farmaceutiska preparat.
DK0402933T3 (da) Anvendelse af fugtig sucralfatgel som bærer for medikamenter med topisk virkning og for kosmetik
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
EP0274104A3 (de) 13-cis-Retinsäure zur Verwendung in Präparaten gegen alternde Haut
IE45054L (en) Veterinary composition
FI861329A (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
EA199900998A1 (ru) Полутвердый фармацевтический препарат, содержащий декскетопрофентрометамол
DE69018570D1 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
HUP9903892A2 (hu) Hidroxámsavszármazékok
DE3880778D1 (de) Therapeutisches mittel, das einen extrakt von impatiens capensis enthaelt.
RU93057943A (ru) Мазь для лечения инвазионных болезней животных
NO904611L (no) Farmasoeytiske preparater inneholdende deoksyribonukleosider for saarheling.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired